87 phenotypes from 3 alleles in 8 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Nsun2Gt(D014D11)Wrst/Nsun2Gt(D014D11)Wrst involves: 129S2/SvPas * C57BL/6J * CBA	abnormal hair cycle	J:179810
	abnormal hair cycle anagen phase	J:179810
	alopecia	J:179810
	decreased body size	J:179810
	male infertility	J:179810
Nsun2tm1a(EUCOMM)Wtsi/Nsun2+ B6Brd;B6Dnk;B6N-Tyrc-Brd Nsun2tm1a(EUCOMM)Wtsi/Wtsi	abnormal hair cycle	J:232539
	abnormal hair shedding	J:232539
Nsun2tm1a(EUCOMM)Wtsi/Nsun2+ B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi	decreased body weight	J:165965
	decreased circulating amylase level	J:175295
	decreased mean corpuscular volume	J:165965
	excessive tearing	J:165965
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi B6Brd;B6N-Tyrc-Brd Nsun2tm1a(EUCOMM)Wtsi/Wtsi	abnormal coat appearance	J:232539
	abnormal hair cycle anagen phase	J:232539
	abnormal snout morphology	J:232539
	disheveled coat	J:232539
	preweaning lethality, incomplete penetrance	J:232539
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi B6JTyr;B6N-Nsun2tm1a(EUCOMM)Wtsi/Wtsi	abnormal cranium morphology	J:175295
	abnormal dorsal root ganglion morphology	J:239583
	abnormal ductus venosus valve morphology	J:239583
	abnormal external carotid artery origin	J:239583
	abnormal eye muscle morphology	J:239583
	abnormal forebrain morphology	J:239583
	abnormal humerus morphology	J:175295
	abnormal hypoglossal nerve topology	J:239583
	abnormal infrahyoid muscle connection	J:239583
	abnormal joint morphology	J:175295
	abnormal lens morphology	J:239583
	abnormal optic chiasm morphology	J:239583
	abnormal optic cup morphology	J:239583
	abnormal optic stalk morphology	J:239583
	abnormal rib morphology	J:239583
	abnormal snout morphology	J:175295
	abnormal systemic artery morphology	J:239583
	abnormal testis morphology	J:239583
	abnormal thymus capsule morphology	J:239583
	abnormal tooth morphology	J:175295
	abnormal vertebral artery topology	J:239583
	absent ductus venosus valve	J:239583
	absent hypoglossal canal	J:239583
	absent hypoglossal nerve	J:239583
	absent segment of posterior cerebral artery	J:239583
	absent stapedial artery	J:239583
	basisphenoid bone foramen	J:239583
	decreased body weight	J:165965
	ductus venosus stenosis	J:239583
	fusion of vertebral arches	J:239583
	increased trigeminal neuroma incidence	J:239583
	intraembryonal intestine elongation	J:239583
	persistent dorsal ophthalmic artery	J:239583
	persistent trigeminal artery	J:239583
	reduced sympathetic cervical ganglion size	J:239583
	retroesophageal right subclavian artery	J:239583
	small superior cervical ganglion	J:239583
	subcutaneous edema	J:239583
	thin hypoglossal nerve	J:239583
	thin motoric part of trigeminal nerve	J:239583
	thoracoschisis	J:239583
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi C57BL/6N-Nsun2tm1a(EUCOMM)Wtsi	abnormal epidermis stratum basale morphology	J:209956
	abnormal hair cycle	J:209956
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi involves: C57BL/6 * C57BL/6N	abnormal cornea morphology	J:213427
	abnormal cranium morphology	J:213427
	abnormal deltoid tuberosity morphology	J:213427
	abnormal fertility/fecundity	J:213427
	abnormal hair cycle anagen phase	J:213427
	abnormal hair shedding	J:213427
	abnormal humerus morphology	J:213427
	abnormal joint morphology	J:213427
	abnormal lens morphology	J:213427
	abnormal liver physiology	J:213427
	abnormal snout morphology	J:213427
	abnormal spine curvature	J:213427
	abnormal tooth morphology	J:213427
	cataract	J:213427
	decreased body length	J:213427
	decreased body weight	J:213427
	decreased bone mineral content	J:213427
	decreased bone mineral density	J:213427
	decreased circulating amylase level	J:213427
	decreased circulating cholesterol level	J:213427
	decreased circulating free fatty acids level	J:213427
	decreased circulating glucose level	J:213427
	decreased circulating glycerol level	J:213427
	decreased circulating HDL cholesterol level	J:213427
	decreased circulating LDL cholesterol level	J:213427
	decreased energy expenditure	J:213427
	decreased grip strength	J:213427
	decreased lean body mass	J:213427
	decreased length of long bones	J:213427
	decreased mean corpuscular hemoglobin	J:213427
	decreased mean corpuscular volume	J:213427
	decreased percent body fat/body weight	J:213427
	decreased total body fat amount	J:213427
	hyperactivity	J:213427
	improved glucose tolerance	J:213427
	increased carbon dioxide production	J:213427
	increased energy expenditure	J:213427
	increased erythrocyte cell number	J:213427
	increased oxygen consumption	J:213427
	kyphosis	J:213427
	lethality, incomplete penetrance	J:213427
	lordosis	J:213427
	oligozoospermia	J:213427
	testis degeneration	J:213427
Nsun2tm1a(EUCOMM)Wtsi/Nsun2tm1a(EUCOMM)Wtsi involves: C57BL/6N	decreased body size	J:179810
	male infertility	J:179810
Nsun2tm1c(EUCOMM)Wtsi/Nsun2tm1c(EUCOMM)Wtsi Tg(KRT14-cre)1Amc/? involves: C57BL/6 * CBA	abnormal hair cycle anagen phase	J:179810